PharmaVoice Logo

Healthcare Leaders Hub

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

ET Pharma

Sep 14, 2026, 2:29 AM

Sun Pharma reaches settlement in US antitrust case over generic drugp Pricing

The company said its US subsidiaries, Sun Pharma Inc. and Taro Pharmaceuticals, will make the settlement payment in exchange for a full release of all claims asserted against them.

ET Pharma

Sep 14, 2026, 2:00 AM

Aurobindo Pharma’s API facility clears FDA inspection

The Unit-IV operated by the company’s wholly owned subsidiary, Apitoria Pharma, was inspected from September 7 to September 11.

ET Pharma

Sep 12, 2026, 2:00 AM

Alembic Pharma's Vadodara bioequivalence facility clears USFDA inspection

In a regulatory filing, the company said the United States Food and Drug Administration (USFDA) carried out the onsite bioequivalence inspection from August 31, 2026, to September 10, 2026.

ET Pharma

Sep 12, 2026, 1:55 AM

GSK to shut vaccine factory in Germany, putting 641 jobs at risk

The closure would put 641 jobs at ‌risk, according ⁠to ⁠German trade union Industriegewerkschaft Bergbau, Chemie, Energie (IGBCE).

PharmaShots

Sep 11, 2026, 1:30 PM

Top 20 Prescription Drugs of 2026

Shots:  20. Vyndaqel Family  Non-Proprietary Name: Tafamidis  Company: Pfizer  First Approved: US (Nov 13, 2015), EU (Feb 1, 2016)    Total Revenue: $6.38B    19. Prevnar Family  Non-Proprietary Name: Pneumococcal Conjugate Vaccines  Company: Pfizer  First Approved: US (Nov 13, 2015), EU (Feb 1, 2016)    Total Revenue: $6.49B    18. Cosentyx  Non-Proprietary Name: Upadacitinib  Company: Novartis  First Approved: US (Jan… The post Top 20 Prescription Drugs of 2026 appeared first on PharmaShots.

Pharma Tech

Sep 11, 2026, 1:10 PM

HIV charities lament NICE snub for Gilead’s twice-yearly lenacapavir

Though yet to be finalised, the initial recommendation would mean the injectable PrEP would not be covered on the NHS.

News

Latest industry coverage

Google News

Sep 14, 2026, 3:30 AM

Monday Motivation: 'Entrepreneurship is about staying the course' - Livemint

Monday Motivation: 'Entrepreneurship is about staying the course'  Livemint

Google News

Sep 14, 2026, 3:18 AM

Canberra details tax changes with limited concessions for some innovators - BiotechDispatch

Canberra details tax changes with limited concessions for some innovators  BiotechDispatch

Google News

Sep 14, 2026, 2:10 AM

Aptar Pharma Expands Preservative Free Technology Production in Latin America - BioSpace

Aptar Pharma Expands Preservative Free Technology Production in Latin America  BioSpace

Google News

Sep 14, 2026, 1:51 AM

Smart Pharmaceutical Packaging Market Forecast Report Featuring Segment Analysis And Strategic Industry Insight - The National Law Review

Smart Pharmaceutical Packaging Market Forecast Report Featuring Segment Analysis And Strategic Industry Insight  The National Law Review

Google News

Sep 14, 2026, 1:11 AM

AI-Driven Pharmaceutical R&D Infrastructure Competition: Key Trends, Strategies & Industry Impact - 36 Kr

AI-Driven Pharmaceutical R&D Infrastructure Competition: Key Trends, Strategies & Industry Impact  36 Kr

Google News

Sep 14, 2026, 12:39 AM

SK Biopharmaceuticals Earns Top MSCI ESG Rating for Third Year - Seoul Economic Daily

SK Biopharmaceuticals Earns Top MSCI ESG Rating for Third Year  Seoul Economic Daily

Google News

Sep 14, 2026, 12:25 AM

SK Biopharmaceuticals Becomes First Korean Pharma to Earn ‘AAA’ MSCI ESG Rating - 아시아경제

SK Biopharmaceuticals Becomes First Korean Pharma to Earn ‘AAA’ MSCI ESG Rating  아시아경제

Google News

Sep 14, 2026, 12:00 AM

Smart Pharmaceutical Packaging Market Forecast Report Featuring Segment Analysis And Strategic Industry Insight - EIN News

Smart Pharmaceutical Packaging Market Forecast Report Featuring Segment Analysis And Strategic Industry Insight  EIN News

Google News

Sep 13, 2026, 10:33 PM

Trump's secretive pharma deals may undermine 'most-favored nation' pricing, an analysis suggests - STAT

Trump's secretive pharma deals may undermine 'most-favored nation' pricing, an analysis suggests  STAT

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer